Cassidie Li, NP

Cassidie Li practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Cassidie Li's NPI, 1831476852, was assigned on November 4, 2011. Cassidie Li holds New York license F336852-1.

Cassidie Li's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Cassidie Li's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Cassidie Li is also affiliated with Tisch Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Cassidie Li to 1 more hospital and 2 clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cassidie Li practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Cassidie Li's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Cassidie Li is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, chronic diabetes, chronic indigestion, contact dermatitis, fluid and electrolyte imbalances, fluid in a joint and itchy rashes among the conditions Cassidie Li treats.

CMS data shows 225 Medicare services from Cassidie Li across 3 procedure codes in 2024, for 139 Medicare patients. Medicare paid $9,515 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Cassidie Li in 2024. The largest group is 75 to 84, with 67 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Cassidie Li's median patient age at 74, with 68% women.

In 2024, Cassidie Li wrote 1,221 Medicare Part D claims for 340 patients. 86% of them were for generic drugs. CMS names the drug for 889 of them, across 29 drugs with 11 or more claims each, at $30,407 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Cassidie Li for performance year 2024, reported through an alternative payment model (APM). Cassidie Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cassidie Li as offering telehealth.

CMS Open Payments shows 1 general payment to Cassidie Li from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Insulet Corporation paid the most, $169.